Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma.

about

Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma.

Item

http://www.wikidata.org/entity/Q45968380

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Inpatient vs outpatient autolo ...... antation for multiple myeloma.

@en

Inpatient vs outpatient autolo ...... antation for multiple myeloma.

@nl

type

Item

label

Inpatient vs outpatient autolo ...... antation for multiple myeloma.

@en

Inpatient vs outpatient autolo ...... antation for multiple myeloma.

@nl

prefLabel

Inpatient vs outpatient autolo ...... antation for multiple myeloma.

@en

Inpatient vs outpatient autolo ...... antation for multiple myeloma.

@nl

P1476

Inpatient vs outpatient autolo ...... lantation for multiple myeloma

@en

P2093

A Megan Cornelison

http://www.w3.org/2001/XMLSchema#string

Chitra Hosing

http://www.w3.org/2001/XMLSchema#string

Elizabeth J Shpall

http://www.w3.org/2001/XMLSchema#string

Muzaffar Qazilbash

http://www.w3.org/2001/XMLSchema#string

Qaiser Bashir

http://www.w3.org/2001/XMLSchema#string

Richard E Champlin

http://www.w3.org/2001/XMLSchema#string

Rima Saliba

http://www.w3.org/2001/XMLSchema#string

Sairah Ahmed

http://www.w3.org/2001/XMLSchema#string

Simrit Parmar

http://www.w3.org/2001/XMLSchema#string

Uday Popat

http://www.w3.org/2001/XMLSchema#string

P2860

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting.

Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost-effective.

Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2.

New developments in conditioning regimens before auto-SCT in multiple myeloma.

Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma.

Cancer Statistics, 2017.

Impact of a change in antibacterial prophylaxis on bacteremia and hospitalization rates following outpatient autologous peripheral blood stem cell transplantation for multiple myeloma.

Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.

Outpatient Autologous Stem Cell Transplantation for Patients With Myeloma.

P304

532-535

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EJH.12970

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nina Shah

P577

2017-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28895206

http://www.w3.org/2001/XMLSchema#string